The Effectiveness Of Bevacizumab And Related Trials

The effectiveness of bevacizumab (Avastin) and related trials

Ovacome - the ovarian cancer charity

Clinical Trials Exploring Bevacizumab in NSCLC

Targeted Oncology

GOG-0218: which patients with ovarian cancer experience highest benefit from 1L bevacizumab?

BEAT-SC: Phase III trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage SCLC

Real-world use of bevacizumab in patients with breast cancer

Global drug pricing: How cost-effective is bevacizumab?

BEAT-meso: Phase III trial of bevacizumab and chemo ± atezolizumab for advanced pleural mesothelioma

Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeuti...

Assessing the Use of Bevacizumab

Dr. Jason A. Konner on Bevacizumab in Advanced Ovarian Cancer

Targeted Oncology

Assessing the safety of pembrolizumab with CAPOX-bevacizumab for CRC in the POCHI trial

DKN-01 with bevacizumab and chemotherapy in advanced CRC

Biomarker-Driven Frontline Ovarian Cancer Treatment

Dr. Brufsky Discusses Bevacizumab Benefits in TNBC

Dr. Rugo on the Efficacy of Bevacizumab in Breast Cancer

Ahmed Kaseb, MD, considers the effectiveness of bevacizumab + atezolizumab in HCC

Key outcomes of the Phase 1b of atezolizumab and bevacizumab for advanced HCC

Study Finds Bevacizumab Prolongs Life Among Patients With Deadly Brain Cancer

What is the Role of Bevacizumab in Stage IV NSCLC?

GRACE - Global Resource for Advancing Cancer Education

1L FOLFOXIRI plus cetuximab or bevacizumab for RAS wild-type mCRC